Literature DB >> 23756501

Death due to an unrecognized groin abscess in a drug addict: a retrospective study.

Cristian D'Ovidio1, Paola Vellante, Sara Costantini, Aldo Carnevale.   

Abstract

Intravenous drug injection persists despite health risks and medical complications. Venous thrombosis, septic thrombophlebitis, artery necrosis, arterio-venous fistula, mycotic aneurysm, dissecting hematoma, pseudoaneurysm formation, and soft tissues infections (i.e. abscesses, cellulitis, infected ulcers), are some of the major clinical consequences lives threatening. The aim of this work is to present this unusual autoptic case of a drug addict man died for an unrecognized groin abscess referred to the Institute of Legal Medicine, University of Chieti, causing femoral vein's erosion, and to analyse the most common patterns of vascular lesions among drug addicts. It could be stimulated a new scientific debate because groin injections and their vascular complications increase over years; while soft tissue infections may hide vascular lesions' diagnosis. So physicians should have a high index of suspicion for serious vascular problems, among intravenous drug users (IDUs): prevention for avoiding groin injection and a proper treatment are necessary.
Copyright © 2013 Elsevier Ltd and Faculty of Forensic and Legal Medicine. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23756501     DOI: 10.1016/j.jflm.2013.03.008

Source DB:  PubMed          Journal:  J Forensic Leg Med        ISSN: 1752-928X            Impact factor:   1.614


  2 in total

1.  Mycotic pseudoaneurysm by vancomycin-intermediate Staphylococcus aureus: a rare cause of persistent bacteraemia.

Authors:  Toufik Mahfood Haddad; Saraschandra Vallabhajosyula; Pranathi Rao Sundaragiri; Renuga Vivekanandan
Journal:  BMJ Case Rep       Date:  2015-04-01

2.  Extensive direct spreading of "groin hit"-related soft tissue infections: a report of three cases.

Authors:  Aleksa Leković; Vladimir Živković; Dragan Ječmenica; Slobodan Nikolić
Journal:  Forensic Sci Med Pathol       Date:  2022-07-18       Impact factor: 2.456

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.